








































Although once thought of as passive state of cell cycle 
arrest, senescent cells are now known to govern 
physiological processes such as tumor prevention and 
tissue repair [1-5].  The senescent state can be induced 
in response to various stressors leading to irreversible 
cell cycle arrest, and often the development of an 
altered secretome.  Such stressors include telomere 
dysfunction, oncogene activation, direct DNA damage, 
elevated intracellular reactive oxygen species (ROS) 
and cell-cell fusion [1-3, 6].  Many triggers of the 
senescent program are associated with a persistent DNA 
damage response (DDR), consequently leading  to  acti- 
 
 







































vation of ataxia telangiectasia mutated (ATM) and 
ataxia telangiectasia and RAD3-related (ATR) [7-9].  
ATM and ATR can inhibit cell cycle progression by 
promoting p53 accumulation, which subsequently 
regulates a number of target genes, including cyclin-
dependent kinase inhibitor p21 (CDKN1A).  Senescent 
cells also undergo significant changes in their chromatin 
organization leading to activation of pRb-p16 pathway 
that acts in parallel with the DDR-p53 pathway to 
induce and sustain the cell cycle arrest [10, 11].  
Therefore, induction of senescence regulated by 
multiple signaling pathways performs essential 
physiological functions by limiting tumorigenesis and 
tissue damage. 






















of  the  immune  system,  thereby  facilitating  tumor  suppression  and  limiting  excess  fibrosis  during  wound  repair.   The
mechanisms by which senescent cells regulate their immune surveillance are not completely understood.   Here we show
that  ligands  of  an  activating Natural  Killer  (NK)  cell  receptor  (NKG2D), MICA  and ULBP2  are  consistently  up‐regulated
following  induction  of  replicative  senescence,  oncogene‐induced  senescence  and  DNA  damage  ‐  induced  senescence.
MICA  and  ULBP2  proteins  are  necessary  for  efficient  NK‐mediated  cytotoxicity  towards  senescent  fibroblasts.    The
mechanisms  regulating  the  initial  expression  of  NKG2D  ligands  in  senescent  cells  are  dependent  on  a  DNA  damage
response, whilst continuous expression of these  ligands  is regulated by the ERK signaling pathway.    In  liver  fibrosis, the
accumulation  of  senescent  activated  stellate  cells  is  increased  in  mice  lacking  NKG2D  receptor  leading  to  increased
fibrosis.  Overall, our  results provide new  insights  into  the mechanisms  regulating  the expression of  immune  ligands  in
senescent cells and reveal the importance of NKG2D receptor‐ligand interaction in protecting against liver fibrosis.   
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Whereas the transient appearance of senescent cells 
plays important physiological roles, long-term 
persistence of senescent cells may promote pathological 
conditions via continuous secretion of pro-inflammatory 
factors [2, 4, 12, 13].  The secretion of chemoattractants 
and the up-regulation of adhesion molecules also forms 
part of an immunogenic phenotype often attributed to 
senescent cells [14, 15].  This phenotype promotes self-
elimination of senescent cells by the immune system 
and can prevent the long-term negative effects 
stimulated by their presence [1, 14, 16].  The interaction 
of senescent cells with the immune system is necessary 
to fulfill the physiological functions of senescent cells 
and to prevent the long-term negative consequences of 
their presence. 
 
One of the main physiological functions of senescent 
cells is tumor suppression [17, 18].  Immuno-
surveillance of senescent cells facilitates this effect.  
Following tumor suppressor reactivation, tumor cells 
become senescent and are targeted by components of 
the innate immune system [19].  Following expression 
of mutant N-RAS, pre-malignant senescent hepatocytes 
undergo immune clearance mediated by an adaptive 
immune response [20].  Impaired immune surveillance 
of these hepatocytes promoted hepatocellular 
carcinomas in mice, demonstrating the importance of 
immunosurveillance of senescent cells as a tumor 
suppressor function. 
 
In addition to its role in tumor suppression, immune 
clearance of senescent cells is necessary to limit short 
term tissue damage response [21, 22].  Induction of cell 
senescence in activated hepatic stellate cells limited 
liver fibrosis following injury.  Subsequently, senescent 
cells are eliminated by Natural Killer (NK) cells to 
ensure proper reversion of fibrosis [21].  To eliminate 
senescent cells NK cells utilize granule exocytosis, but 
not death-receptor mediated pathway which is inhibited 
in senescent cells by DCR2 [23].  The granule 
exocytosis pathway is necessary for clearance of 
senescent cells in fibrotic livers and therefore for 
restraining fibrosis development.  NK cell mediated 
immune surveillance is therefore necessary for the 
immunosurveillance of senescent cells during 
tumorigenesis, tumor therapy and tissue damage. 
 
NK cells are a component of the innate immune 
system that rapidly responds to virally infected and 
tumor cells [24, 25].  One of the receptors responsible 
for the activation of the NK cells, NKG2D (NCBI 
symbol KLRK1) receptor, is implicated in interaction 
of NK cells with senescent cells during tumorigenesis 
and tumor therapy [26, 27].  NKG2D receptor 
recognizes ligands MICA/B and ULBP1-6 on the 
surface of stressed cells leading to direct cytotoxicity 
[24, 28, 29].   
 
To date, our understanding concerning the interaction of 
senescent cells with NK cells comes primarily from a 
limited number of studies which focused on senescence 
induction in cancer cells rather than physiologically 
normal cells [26, 27].  Senescent cells derived from 
such normal cells accumulate at sites of tissue damage 
and during ageing.  Therefore, we investigated the 
mechanisms regulating the interaction of senescent cells 
derived from normal cells with NK cells.  We show that 
senescent cells induced by various stimuli present 
NKG2D ligands MICA and ULBP2 on their cell 
surface, enabling their recognition and elimination by 
NK cells.  The expression of the ligands is regulated by 
a DNA damage response and ERK signaling. NKG2D 
receptor knockout in mice prevents efficient elimination 
of senescent cells during liver damage, leading to 
increased liver fibrosis.  Overall, our study provides 
new insights into the mechanisms of immuno-





Expression of NKG2D ligands is elevated in 
senescent cells 
   
NK cell mediated immune surveillance of senescent 
cells limits tumorigenesis and tissue damage.  To fulfill 
this function NK cells preferentially induce cell death in 
senescent cells via the granule exocytosis pathway [23].  
We aimed to determine the mechanisms by which NK 
cells can specifically recognize senescent cells, leading 
to activation of the specific cytotoxicity towards 
senescent cells.  NK cells express NKG2D receptors, 
which were previously implicated in interaction 
between NK cells and damaged cells, including cancer 
cells undergoing senescence in response to p53 
reactivation or chemotherapy [19, 26, 27].  We 
therefore evaluated whether cells undergoing 
senescence in response to classical stimuli trans-
criptionally upregulate common NKG2D ligands.  In 
human cells these ligands are ULBP1-6, MICA and 
MICB.  Normal human fibroblast IMR-90 cells were 
induced to senesce via direct DNA damage through 
treatment with etoposide (DIS), replicative senescence 
(RS) associated with telomere shortening by extended 
cell culture and oncogene induced senescence (OIS) via 
overexpression of H-RASv12.  Cell senescence was 
confirmed using several common biomarkers (Fig S1) 
and the expression level of the different NKG2D 
ligands were assessed.  The NKG2D ligands MICA, 
ULBP1 and ULBP2 were consistently upregulated at 
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least two-fold in all three types of senescent IMR-90 
fibroblasts compared to growing control cells (p<0.05; 
Fig 1A,B,C for DIS, RS and OIS cells, respectively).  
Of note, in addition to MICA, ULBP1 and ULBP2, a 
five-fold increase in ULBP4 expression was observed in 
OIS cells but not DIS or RS cells in comparison to 
growing cells (p<0.0001; Fig 1C).  Therefore, senescent 
IMR-90 cells upregulate mRNA levels of several 
ligands of NKG2D receptor.  
 
To exclude the possibility that the expression of MICA, 
ULBP1 and ULBP2 was specific to IMR-90 fibroblasts, 
the expression of these ligands was determined in 
additional fibroblasts strains, namely WI38 and BJ, 
which were induced to senesce via DNA damage 
treatment.  Similarly to IMR-90 cells, senescent WI38 
and BJ fibroblasts significantly elevated the expression 
of MICA, ULBP1 and ULBP2 compared to growing 
cells (p<0.05; Fig 1D,E for WI38 and  BJ,  respectively).   



































sion of ULBP4 and ULBP5 over two-fold compared to 
growing cells (p<0.05; Fig 1E).  To evaluate the 
expression of the ligands in a physiologically relevant 
cell type, we assessed the expression of NKG2D ligands 
in activated hepatic stellate cells (HSCs).  These cells 
become senescent during liver fibrosis and are essential 
in limiting the fibrotic response [21].  In concordance 
with the previous results, a significant two-fold elevation 
in MICA and ULBP2 was observed compared to 
growing activated HSCs (p<0.05; Fig 1F).  However, 
senescent cells derived from activated HSCs did not 
upregulate ULBP1 (Fig. 1F).  In addition, senescent 
activated HSCs elevated MICB, ULBP4 and ULBP5 
compared to growing cells (p<0.0001 each; Fig 1F).  
Overall, these findings demonstrate that senescent cells 
upregulate the expression of NKG2D ligands.  
Importantly, this upregulation occurs regardless of the 
senescence-inducing stimuli, and the exact expression 
profile of these NKG2D ligands can differ between cell 




































Figure  1.  Senescent  cells  upregulate  NKG2D  ligands.  RT‐PCR  analysis  demonstrates  a  consistent  up‐
regulation of MICA, ULBP1, and ULBP2 in DNA damage‐induced senescent (DIS) (A), replicative senescent (RS) (B),
and H‐RASv12‐mediated oncogene‐induced senescent (OIS) (C)  IMR‐90 fibroblasts compared to growing (control)
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MICA and ULBP2 proteins are up-regulated and 
localized to the cell surface of senescent cells 
  
Localization of ligands to the plasma membrane allows 
interaction of target cells with immune cells.  Therefore, 
we wanted to determine whether NKG2D ligands are 
localized to the cell surface membrane of senescent 
cells utilizing DIS cells as a proof of principle model.  
To this end, we focused on MICA and ULBP2 
localization, since they are consistently upregulated at 
the mRNA level in all senescent cells we evaluated, 
particularly in HSCs, a physiologically relevant cell 
type (Fig 1).  We used the ImageStreamX system, that 
combines imaging and flow cytometry, to monitor the 
intensity and localization of the MICA and ULBP2 








































Total and membrane bound intensity of MICA or 
ULBP2 proteins in DIS IMR-90 cells was subsequently 
measured.  This analysis revealed that total intensity of 
MICA and ULBP2 was elevated two-fold (p<0.001 for 
MICA and p<0.0001 for ULBP2; Fig 2B), and the 
intensity of the protein on the cell membrane was also 
elevated two-fold in senescent cells compared to 
growing cells (p<0.05 for MICA and p<0.0001 for 
ULBP2; Fig 2B).  Of note, performing standard flow 
cytometry analysis on DIS IMR-90 cells also confirmed 
MICA and ULBP2 protein upregulation on the cell 
surface membrane (Fig S2A).  Increased protein 
abundance of MICA and ULBP2 was also observed in 
DIS WI38, BJ and IMR90 cells compared to growing 












































immunofluorescence  staining  of  MICA  and  ULBP2  performed  on  non‐permeabilized  cells  demonstrates  higher
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cytochemistry (Fig 2C and Fig S2B).  These findings 
demonstrate that the transcriptional upregulation of 
MICA and ULBP2 is subsequently correlated with an 
elevation in protein abundance, localized at the cell 
membrane where they can be potentially identified by 
NK cells.   
 
MICA and ULBP2 facilitate NK cell mediated 
cytotoxicity towards senescent cells 
 
Following the presentation of NKG2D ligands on the 
cell surface of stressed cells, NK cells expressing 
NKG2D receptors can recognize and interact with these 
cells to promote specific cytotoxicity [24, 30].  We have 
previously showed that NK cells exhibit specific 








































Of note, our cytotoxicity methodology quantifies the 
remaining viable cells at the end of the co-incubation 
period using a viability assay. Traditional NK-mediated 
cytotoxicity assays  that rely on the loading of the target 
cells with 51Cr cannot be applied when using senescence 
cells since efficient loading requires a threshold level of 
cell proliferation [31] which cannot be achieved in 
senescent cells. NKG2D ligands are present on the 
membrane of senescent cells (Fig 2), and we now aimed 
to determine whether these ligands are required for NK 
cell mediated cytotoxicity towards senescent fibroblasts.  
We treated DIS senescent IMR-90 cells with blocking 
antibodies against MICA and ULBP2 and incubated 
these cells with either the NK92 NK cell line (Fig 3A) 
or primary human NK cells (Fig 3B) and assessed the 







































Figure 3. NKG2D  receptor‐ligand  interaction mediates  the  recognition of  senescent  cells by NK  cells. Growing  and 
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either MICA or ULBP2 alone reduced NK92 mediated 
cytotoxicity towards senescent cells by 25% (p<0.05; 
Fig 3A), whereas combined inhibition of MICA and 
ULBP2 reduced cytotoxicity by NK92 and primary NK 
cells to less than a half comparing to isotype control 
antibody (p<0.05; Fig 3A,B).  To evaluate the 
contribution of the NKG2D receptor itself for the 
recognition of senescent cells, we blocked the NKG2D 
receptors on NK cells using blocking antibodies prior to 
co-culture with senescent cells.  Blocking of the 
receptor significantly reduced the cytotoxicity towards 
senescent cells by both NK92 and primary NK cells 
(80%, p<0.001 for NK92 and 90%, p<0.0001 for 
primary NK ; Fig 3A,B).  Therefore, blocking the 
interaction between MICA, ULBP2 and their receptor 
NKG2D significantly reduces the NK cell mediated 
cytotoxicity towards senescent cells. 
 
To evaluate the effect of the ligands on the recognition 
of senescent cells by NK cells using an independent 
approach, the expression of MICA and ULBP2 was 
down-regulated using specific siRNA mixes.  The 
siRNAs induced at least 75% knockdown of MICA and 
ULBP2 as was confirmed by quantitative RT-PCR 
(p<0.0001, Fig 3C and D for MICA and ULBP2, 
respectively).  Knockdown of either MICA or ULBP2 
alone reduced NK92 mediated cytotoxicity by one third 
(p<0.05; Fig 3E), whereas combined knockdown of 
MICA and ULBP2 completely blocked the cytotoxicity 
of NK cells towards DIS cells (p<0.0001; Fig 3E).  
Therefore, expression of MICA and ULBP2 in 
senescent cells is necessary for the NK mediated 
cytotoxicity towards these cells.  Overall, these 
findings demonstrate that NKG2D receptor-ligand 
interaction is essential for NK mediated killing of 
senescent cells.   
 
DNA damage response upregulates expression of 
ULBP2, but not MICA 
   
To understand the regulation of the interaction between 
senescent cells and NK cells, we aimed to underpin the 
mechanisms that promote transcriptional upregulation 
of NKG2D ligands during induction of senescence.  
Importantly, we observed a correlation between the 
levels of MICA and ULBP2 mRNA transcripts and the 
levels of protein expression on the cell surface 
membrane in senescent cells (Fig. 1A and Fig. 3). 
Therefore, we decided to focus our studies on the 
molecular mechanisms regulating mRNA expression of 
NKG2D ligands in senescent cells.  NKG2D ligands 
can be upregulated in response to different forms of 
cellular stress, including DNA damage [27, 32].  DDR 
is activated in senescent cells and therefore we wanted 
to understand the contribution of this pathway to the 
regulation of MICA and ULBP2 expression.  The 
upregulation of the ligands following genomic stress 
could either be an early response that is subsequently 
maintained when cells enter senescence or be a 
senescence specific response that occurs at later time 
points.  To distinguish between the two possibilities we 
determined the expression dynamics of MICA and 
ULBP2 over a nine-day period leading to a full 
senescent phenotype in IMR-90, WI38 and BJ cells.  
The expression of MICA (Fig 4A) and ULBP2 (Fig 4B) 
was determined at days 0, 1, 3, 5, 7 and 9 following 
treatment of proliferating cells with 100μM etoposide.  
The expression of MICA is elevated at least by two-
folds within 24hrs of etoposide treatment and is 
maintained consistently high throughout the nine days 
in all cell strains (p<0.001; Fig 4A).  ULBP2 expression 
has a slightly different expression pattern associated 
with an initial elevation in expression by about three-
fold within the first 24hrs, which subsequently 
decreased but was maintained consistently upregulated 
about two-fold (p<0.001) throughout the nine days 
compared to non-senescent control cells (Fig 4B).  In 
contrast, cells treated with 10μM etoposide to induce 
transient DNA damage and cell cycle arrest rather than 
cell senescence demonstrated an initial one and a half-
fold upregulation of MICA (p<0.05, Fig 4C) and two-
fold upregulation of ULBP2 (p<0.001).  By day 3, 
ULBP2 levels decrease by 50% compared to growing 
cells following treatment with 10μM etoposide for 
24hrs  (p<0.001, Fig 4C), while MICA levels remain 
stable.  Therefore, short-term DNA damage can activate 
transient upregulation of NKG2D ligands. 
 
To determine whether the upregulation of MICA and 
ULBP2 is a response to cell cycle arrest or rather a 
response to DNA damage, IMR-90 cells were grown to 
confluence and cells were maintained for a further 7 
days to induce quiescence via contact inhibition, a 
growth arrested state absent of DNA damage.  
Quiescence was validated by the absence of the 
proliferation marker Ki67 (Fig S3) and the ability to re-
enter the cell cycle when subsequently sub-cultured.  
Strikingly, quiescent IMR-90 cells do not upregulate the 
expression of MICA or ULBP2, but rather 
downregulate ULBP2 expression (50%, p<0.0001) 
compared to proliferating controls (Fig 4D).  Therefore, 
cell cycle arrest by itself does not contribute to the 
upregulation of the expression of the NKG2D ligands. 
 
To assess whether the upregulation of MICA and 
ULBP2 expression is regulated by DDR, proliferating 
IMR-90 cells were pretreated with the ATM inhibitor 
(KU60019) for one hour prior to the addition of 100μM 
etoposide.  Expression level of MICA and ULBP2 was 
evaluated twenty four hours following the treatment.   
  


















































Cells pretreated with the ATM inhibitor did not 
upregulate expression of ULBP2 whilst MICA is still 
upregulated compared to etoposide only treated cells 
(p<0.0001; Fig 5A).  To evaluate the possibility that 
MICA may instead be regulated via ATR, or by both 


















































med the experiments using caffeine, an inhibitor of both 
ATM and ATR.  Pre-treatment with caffeine prevented 
upregulation of ULBP2, whereas a further upregulation 
was observed with MICA expression (p<0.05; Fig 5B).  
To determine the regulation of MICA and ULBP2 
expression in cells that have already been established as 
Figure 4. MICA and ULBP2 expression is stably upregulated in senescent, but not quiescent cells. Growing
IMR‐90, WI38 and BJ  cells were  treated with Etoposide  (100μM) and  the  level of MICA and ULBP2 expression were
assessed by RT‐PCR. The expression of MICA  (A) and ULBP2  (B) was elevated 24 hours  following  treatment and was
maintained at higher levels throughout the indicated time points. Growing cells at day 0 served as control. (C) Growing
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senescent, DIS IMR-90 fibroblasts were treated with the 
ATM inhibitor for 24, 48, 72 and 96 hours with daily 
replenishments.  ATM inhibition caused a 25% 
reduction in ULBP2 expression within twenty four 
hours (p<0.001), with further reductions at later time 
points (>50%, p<0.0001, p<0.05 and p<0.001 for 48, 72 
















































However, ATM inhibition also further increased MICA 
expression throughout all time points observed (p< 0.001 
for 48 and 72 hours and p<0.05 for 96 hours; Fig 5C,D).  
Therefore, upregulation of ULBP2 during cell senescence 
appears to be dependent upon a DNA damage response, 
whereas the upregulation of MICA is controlled by 










































































































ERK activity regulates the expression of MICA and 
ULBP2 
 
One of the signaling pathways constitutively activated 
during cell senescence is ERK (Fig 6A and [33]).  In 


















































governing the expression of immune ligands in 
senescent cells, we analyzed the role of ERK signaling 
in regulating expression of NKG2D ligands.  
Phosphorylation of ERK increases its activity and MEK 
is the kinase that phosphorylates and activates ERK.  In 
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expression of NKG2D ligands in senescent cells, DIS 
and OIS IMR-90 cells were maintained in the presence 
of a MEK inhibitor (PD184352) for 48 hours.  Western 
blot analysis confirmed inhibition of ERK 
phosphorylation in this setting (Fig 6A).  We then 
assessed the expression of MICA and ULBP2 in 
senescent cells treated with PD184352 or a vehicle 
control (DMSO) and in growing cells.  In the presence 
of PD184352, no change in the expression of MICA 
was observed, whereas a substantial decrease (>50%) in 
ULBP2 expression was observed within DIS and OIS 
cells (p<0.0001 and p<0.05 for DIS and OIS, 
respectively; Fig 6B,C).  Similarly, ERK inhibition in 
DIS WI38 cells caused ULBP2 downregulation with no 
impact on MICA expression (Fig S4).  In addition to 
PD184352, two additional MEK inhibitors (AZD6244 
and GSK1120212) were evaluated for their effect on 
MICA and ULBP2 expression in senescent cells over 
24, 48, 72 and 96 hours (Fig 6D,E).  Whilst these MEK 
inhibitors caused a mild elevation in MICA expression 
within the first 24hrs, at later time points they lead to a 
25% to 50% reduction in MICA expression, particularly 
by 72 and 96hrs following treatment (p<0.05; Fig 6F).  
These inhibitors caused a 20% reduction in ULBP2 
within 24 hours and further reductions between 25% 
and 60% at later time points (p<0.05; Fig 6G).  To rule 
out the possibility that decreases in ligand expression at 
later time points was due to cells dying rather than ERK 
inhibition per se, cell viability was determined at each 
time point.  No significant difference in cell viability 
was observed in cells treated with MEK inhibitors 
compared to DMSO treated cells (Fig S5).  Therefore, 
ERK signaling is essential for the continuous expression 
of MICA and ULBP2 in senescent cells. 
 
In addition to NKG2D ligands, the immune surveillance 
of senescent cells by NK cells is also regulated by other 
immune ligands as well as the senescent secretome, 
functioning to attract immune cells to the sites of 
senescent cells [14, 25].  Interestingly, ERK inhibition 
in DIS IMR-90 cells downregulated PVR but not 
ICAM-1 (Fig S6), two immune modulators that are 
implicated in NK-mediated cytotoxicity [34, 35].  
Furthermore, ERK inhibition promotes downregulation 
in the expression of components of the senescent 
secretome (IL-6, IL-8, CXCL1, CXCL10 and CCL2) 
that can act as chemoattractants for immune cells (Fig 
6H).  These findings suggest that ERK activity in 
senescent cells is important for their interaction with 
NK cells by regulating the expression of NKG2D 
ligands, specifically MICA and ULBP2, and the 
expression of chemoattractants.   
 
NKG2D is required for NK cell mediated immune 
surveillance of senescent cell in vivo 
 
In response to tissue damage within the liver, hepatic 
stellate cells (HSCs) become activated and undergo 
proliferative expansion that is associated with 
deposition of extracellular matrix (ECM) components 
[36].  To prevent excess fibrosis, activated HSCs 
undergo senescence and are subsequently eliminated by 
NK cells [21].  We wanted to determine whether 
NKG2D receptor-ligand interactions are required for 
NK-mediated immune clearance of senescent cells in 
vivo in liver fibrosis.  Importantly, murine Nkg2d-
ligands were shown to be upregulated in fibrotic livers 
of WT mice and to mediate NK killing of activated 
HSCs in an Nkg2d-dependent manner thereby 
ameliorating liver fibrosis in these mice [37].  To 
evaluate this we induced fibrosis in wild-type (WT) and 
Nkg2d knockout (Nkg2d−/−) C57BL/6 mice by 12 
consecutive bi-weekly injections of CCl4.  To assess 
fibrosis progression, liver sections from CCl4 and 
vehicle treated mice were stained with Hematoxylin and 
Eosin (H&E) (Fig 7A).  Fibrosis was not detected in 
vehicle treated mice, nor were there any detectable 
differences in liver architecture between WT 
and Nkg2d−/− mice.  As expected, livers from CCl4-
treated mice of both genotypes displayed a 
characteristic fibrotic histology (Fig 7A).  The fibrosis 
is characterized by activation of HSCs and deposition of 
extracellular matrix (ECM) by these cells.  The amount 
of activated HSCs and the amount of ECM deposited in 
the fibrotic scar are criteria for evaluation of the 
progression of fibrosis [36].  We therefore evaluated the 
ECM deposition and the amount of HSCs in fibrotic 
livers of WT and Nkg2d−/− mice.  Fibrotic scars were 
identified by Sirius Red staining and quantified using 
morphometric analysis of whole-liver sections.  The 
fibrotic scar area is increased by 50% in Nkg2d−/− mice 
comparing with WT (p<0.05; Fig 7A,B).  The relative 
abundance of activated HSCs was assessed by 
expression of the HSC marker αSMA (alpha smooth 
muscle actin) in whole-liver lysates.  Immunoblotting 
and RT-PCR analysis revealed more than two-fold 
increase in mRNA levels of αSMA and a corresponding 
increase in its protein level in CCl4-treated Nkg2d−/− 
livers compared with WT controls (p<0.0001; Fig 
7C,D).  These results indicate an increase in fibrosis and 
impaired elimination of HSCs in Nkg2d−/− mice. 
 
To determine whether the NKG2D-ligand interactions 
influences the abundance of senescent cells, we 
examined Nkg2d−/− and WT fibrotic livers for the 
senescent marker SA-β-gal following CCl4 treatment.  
Consistent with our previous reports [21, 23], SA-β-gal  
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positive cells were found predominantly in the livers of 
CCl4-treated mice and in areas adjacent or within the 
fibrotic scars (Fig 7E).  Quantitative imaging of the 
tissue area occupied by SA-β-gal-positive cells showed 
a 45% increase in senescent cells retained 

















































Fig 7E,F).  In summary, these findings demonstrate that 
NKG2D receptor-ligand interaction is important for the 
elimination of senescent cells in vivo and that lack of 
NKG2D impairs immune clearance of senescent cells, 
thereby contributing to excess tissue fibrosis following 















































Figure 7.  NKG2D receptor promotes senescent cell clearance and  limits  liver fibrosis  in vivo. Nkg2d knockout
(Nkg2d −/−) and WT mice were treated with CCl4 to induce fibrosis. (A) H&E and Sirius red staining was undertaken on liver
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DISCUSSION 
 
Senescent cells are specifically recognized and 
eliminated by NK cells [19, 21, 23, 26, 27].  In this 
study we investigated the mechanisms which control the 
recognition of senescent cells by NK cells.  We found 
that senescent cells up-regulate the expression of 
NKG2D ligands MICA and ULBP2 regardless of the 
senescence-inducing stimuli.  The mechanisms 
regulating the expression of NKG2D ligands in 
senescent cells are partly attributed to a DNA damage 
response and activation of ERK activity.  MICA and 
ULBP2 were found to be localized at the cell membrane 
where they can interact with NK cells to mediate 
efficient killing of senescent cells.  Interaction of the 
ligands with the NKG2D receptor on the NK cells is 
necessary for the recognition of senescent cells by the 
NK cells in vitro.  Importantly, NKG2D receptor-ligand 
interaction is essential for efficient elimination of 
senescent cells in vivo and thus for restraining fibrosis 
development.  Overall, our findings demonstrate that 
NKG2D ligands on senescent cells are necessary for 
efficient recognition and elimination of senescent cells 
in vitro and during tissue damage in vivo. 
 
The increase in expression of NKG2D ligands, 
particularly MICA and ULBP2, is likely a general 
feature of human senescent cells.  A number of other 
studies have demonstrated the expression of MICA 
and/or ULBP2 in senescent cells derived from different 
cell types, namely human activated stellate cells [21], 
replicative senescent human umbilical vein endothelial 
cells [38] and chemotherapy-induced senescent multiple 
myeloma cells [27].  Furthermore, senescent cells also 
acquire unique NKG2D ligand expression profiles 
consisting of several additional NKG2D ligands that 
result from differences between cell types (or cell-
strains) and the mechanism by which senescence was 
induced.  The repertoire of NKG2D ligands in mice is 
vast and similar to human cells, however based on 
sequence comparisons, mouse ligands are not 
homologous to the human ligands [28, 39].  Of note, 
NKG2D ligands are present on mouse cells that become 
senescent following p53 reactivation, and participate in 
the interaction of these cells with NK cells [19, 26].  In 
addition to their expression in senescent cells, NKG2D 
ligands are upregulated in other cell contexts related to 
cellular stress, including cancer, virally infected cells or 
following DNA damage [24, 25, 28, 39].  Therefore, the 
expression of these ligands might be part of a general 
stress response of cells that is utilized by senescent 
cells.   
 
The expression of NKG2D ligands in senescent cells is 
independent of cell cycle arrest and regulated by several 
pathways activated in senescent cells in parallel, rather 
than an individual pathway.  This is supported by 
findings in mice demonstrating that quiescent hepatic 
stellate cells do not express the NKG2D ligand, RAE-1, 
whereas high levels are observed in activated stellate 
cells, a cell response associated with induction of 
fibrosis and senescence in this cell type [21, 37].  
Similarly, the senescent secretome is independent of 
cell cycle arrest and regulated by interconnected 
pathways involving DDR, p38, NF-κB, IL-1β and 
mTOR [1, 40-46].  Various triggers of cellular 
senescence lead to activation of persistent DDR which 
could lead to the upregulation of NKG2D ligands we 
observed.  Indeed, DNA damage was previously shown 
to induce expression of NKG2D ligands in normal 
mouse cells and human cancer cells [27, 32].  However, 
additional mechanisms in parallel with DDR likely also 
regulate the expression of ligands.  For example, Ras 
can induce expression of Nkg2d ligands in mouse cells 
independent of DDR [47].  In addition, type I 
interferon’s contribute to the expression of both MICA 
and ULBP2 once cells have become senescent [48].  
Interestingly, IFN expression has also been shown to be 
induced by DNA damaging agents, consequently 
contributing to senescence induction by further 
amplifying the DNA damage responses [49].  
Unexpected was the observation that inhibition of ATM 
elevated MICA expression but reduced ULBP2 
expression, suggesting that MICA is suppressed rather 
than activated by DDR during senescence.  
  
Another pathway that is active in senescent cells is 
extracellular signal-regulated kinase 1/2 (ERK1/2) 
cascade.  ERK signaling is a central signaling pathway 
that regulates proliferation, survival, and also stress 
response [50].  However, several studies suggest that 
phosphorylated ERK localization maintains 
cytoplasmic, but not nuclear, within senescent cells [51-
53].  Therefore, ERK could regulate NKG2D ligand 
expression in senescent cells by mechanisms 
independent of transcriptional regulation.  Our findings 
suggest that the mRNAs coding for NKG2D ligands 
might be stable in senescent cells and therefore it is 
conceivable that ERK promotes mRNA stability via 
downregulation of miRNA activity.  In fact, MICA and 
MICB have been reported to be regulated by 
endogenous miRNAs in tumors and following 
cytomegalovirus infection [39].  The longer time frame 
required to observe the same decline in MICA 
expression following ERK inhibition compared to 
ULBP2 expression may reflect differences in the 
regulation of mRNA stability between the two ligands.  
In addition to regulation of NKG2D ligands, ERK 
signaling in senescent cells regulates expression of 
chemokines that can serve as chemoattractants for NK 
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cells and other immune cells.  The expression of these 
cytokines is also regulated by the DDR [44].  This 
implies that multiple components of the senescent 
phenotype are responsible for their interaction with the 
immune system, regulated via the DDR and ERK 
signaling.  It would be important to determine if other 
aspects of non-cell-autonomous interactions of stressed 
cells, like intercellular protein transfer [54], are also 
regulated by these pathways. 
 
The accumulation of senescent cells in livers of Nkg2d 
knockout mice following tissue damage demonstrates 
the importance of the Nkg2d mediated recognition for 
the removal of senescent cells and prevention of excess 
fibrosis.  These effects are similar to the ones observed 
in Prf1 knockout mice, where cytotoxic ability of NK 
cells is impaired [23].  In addition to NK cells, T-cell 
subsets also display NKG2D receptors [28, 39], 
suggesting that immunosurveillance of senescent cells 
could be a combined function of both NK cells and T-
cells.  T-cells play an essential role in immuno-
surveillance of hepatocytes induced to senescence by 
expression of mutant N-RAS [20].  However, this 
pathway of immunosurveillance is dependent on antigen 
presentation and therefore might be independent of 
NKG2D receptors.  Another NKG2D independent 
immune system component involved in immuno-
surveillance of senescent cells are macrophages.  
Therefore, immunosurveillance of senescent cells is a 
complex program and a combination of innate and 
adaptive immune system is responsible for the proper 
clearance of senescent cells from the organism.  The 
efficient elimination of senescent cells might not only 
be necessary for restraining fibrosis and enhancing 
tumor suppression.  Whilst it is not known why 
senescent cells accumulate in later life, it has been 
suggested that ageing of the immune system may lead 
to impaired elimination of senescent cells, thereby 
promoting their accumulation within tissues [15, 55].  
The expression of NKG2D receptors on NK cells does 
not appear to alter with age, but decreases in NK 
activity have been reported [55].  Therefore, impaired 
elimination of senescent cells could lead to their 
accumulation in tissues in pathological conditions and 
ageing.  
 
Our findings add to the emerging conceptual idea that 
the senescent program might represent a change in cell 
state that is associated with conversion to an 
immunogenic phenotype, functioning to remove 
damaged cells by immune clearance rather than through 
apoptosis.  In addition to the upregulation of NKG2D 
ligands, the secretion of chemoattractants or the 
expression of adhesion molecules are further examples 
by which senescent cells become immunogenic.  
Immune clearance of senescent cells is likely beneficial 
in complex organisms where the regenerative capacity 
is dependent on non-resident stem cell populations and 
therefore temporal preservation of tissue architecture is 
necessary.  Elimination of senescent cells following 
short-term insults, mediated by immune clearance, has 
physiological functions in tumor suppression and 
wound healing.  Moreover, inefficient clearance might 
lead to the long-term persistence of senescent cells in 
tissues that has been associated with promotion of 
cancer development, ageing and age-related disease [2, 
4, 12].  Therefore, understanding the normal processes 
and mechanisms by which senescent cells are 
eliminated by the immune system will enable the 
formulation of conjectures concerning the mechanism 
responsible for impaired senescent cells elimination in 
later life.  Such an understanding could lead to novel 
therapeutic strategies that enhance elimination of 
senescent cells by the immune system to improve tissue 
repair, cancer therapy and prevent deleterious effects of 
accumulation of senescent cells. 
 
MATERIALS AND METHODS 
 
Tissue culture and cytotoxicity assays. Human diploid 
fibroblasts, IMR-90 and WI38 (ATCC, Manassas, VA, 
USA), human foreskin fibroblasts BJ (ATCC, 
Manassas, VA, USA) and primary human hepatic 
myofibroblasts (activated HSCs) (Dominion 
Pharmakine, Derio – Bizkaia, Spain) were grown in 
standard conditions (DMEM supplemented with 10% 
FCS, 1% L-Glutamine and 1% Penicillin-Streptomycin 
and kept at 37°C with 7.5% CO2). DNA damage-
induced senescent cells were generated by treating 
growing cells with Etoposide (100 μM, Sigma) for 48 
hours. Cells were considered senescent 7 days after 
Etoposide removal. Oncogene induced senescence was 
achieved by retroviral infection of IMR-90 cells with 
mCherry-H-Rasv12 or mCherry as control as previously 
described [54], and cells were considered senescent 9 
days after the end of infection. NK-92 NK cell lines 
(ATCC, Manassas, VA, USA) were grown according to 
the ATCC instructions. 
  
In vitro cytotoxicity assays using the NK cell line, NK-
92, were performed as described previously [21].  
Briefly, growing or DIS IMR-90 cells were plated in a 
12-well plate at 5X105 per well; 10X105 NK-92 cells 
were subsequently added to each well. Following 2 
hours of co-incubation, NK-92 cells were washed gently 
and the cytotoxicity was determined based on 
quantification of remaining adherent cells using Presto 
Blue (Life Technologies, CA, USA) according to the 
manufacturer’s instructions.  
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For in vitro cytotoxicity assays performed with primary 
human NK cells (gift from O. Mandelboim, The 
Hebrew University Hadassah Medical School, 
Jerusalem, Israel), target cells were plated in 12-well 
plates at 4x104 cells per well; 1x105 NK cells (more 
than 99% of CD56+;CD3- [56] were subsequently added 
to each well. Following 2 hours of co-incubation, 
primary NK cells were washed gently and the 
cytotoxicity was determined based on quantification of 
remaining adherent cells using Presto Blue (Life 
Technologies, Carlsbad, California) according to the 
manufacturer’s instructions.  
 
For in vitro cytotoxicity assays using blocking antibodies, 
growing or senescent cells were plated in 24 well plates 
at 2x105 cells per well. Growing and senescent cells were 
treated with blocking antibodies against MICA, ULBP2, 
and a mix of the isotype controls IgG2A and IgG2B 
according to the manufacturer’s instructions (R&D 
Systems, MN, USA). In brief, the blocking antibodies at 
the indicated concentrations were added to each well in 
200µl of 10% complete RPMI (1% Glutamine, 1% Non-
essential Amino Acids, 1% Pyruvate, 1% pen-strep and 
10% FCS) and incubated for 40 minutes at 37°C. 
Subsequently, 5x105 of either NK92 cells or primary NK 
cells were co-cultured with the treated target cells. 
Following 2 hours of co-incubation, NK92 or primary 
NK cells were washed gently and the cytotoxicity was 
determined based on quantification of remaining adherent 
cells using Presto Blue (Life Technologies, Carlsbad, 
California, USA) according to the manufacturer’s 
instructions. When using the blocking antibody against 
NKG2D, NK92 or primary NK cells were pre-incubated 
in the presence of αNKG2D for 40 minutes, washed, and 
then added to either growing and senescent cells. The 
cytotoxicity assay was done as described above. 
 
For in vitro cytotoxicity assays using siRNA against 
MICA and ULBP2. ON-TARGETplus SMARTpool 
small-interfering RNA targeting MICA, ULBP2 and the 
nontargeting (control) pool were transfected into 
growing IMR-90 cells with Dharmafect 1 reagent (all 
from Dharmacon, Lafayette, CO, USA) according to the 
manufacturer’s instructions. 48 hr after transfections 
cells were treated with 100μM Etoposide (Sigma) for 48 
hours. Subsequently, a second transfection was 
performed using siRNA against MICA, ULBP2 and the 
nontargeting (control) pool to ensure gene knockdown 
for 9 days until cells become fully senescent. Then, a 
cytotoxicity assay using NK-92 cell was performed as 
described above. 
  
Mice. The Nkg2d-/- mice development and 
characterization was described previously [57]. C57Bl6 
mice served as controls. For fibrosis induction, the mice 
were treated twice a week, with i.p. injection of 1 ml/kg 
CCl4, for 6 weeks as described [21]. Formalin-fixed 
paraffin-embedded tissues were sectioned and stained 
either with hematoxylin–eosin for routine examination, 
or with Sirius red for visualization of fibrotic 
deposition.  For analysis of relative fibrotic area and 
SA-β-gal activity, Images were taken from multiple 
slides using 3D Histech Panoramic MIDI Digital slide 
scanner (3DHISTECH Kft., Budapest, Hungary). The 
relative fibrotic area was calculated using the Fiji 
software [58]. The Relative fibrotic area was calculated 
by dividing the total Sirius red area by the total 
analyzed area. At least 7 mice were analyzed from each 
genotype. SA-β-gal activity was quantified (from at 
least 6 mice of each genotype) using 3D Histech 
HistoQuant software (3DHISTECH Kft., Budapest, 
Hungary). Areas of SA-β-gal activity were detected 
based on color and their total area was divided by the 
total analysis area.  
 
SA-β-gal staining. Detection of SA-β-Gal activity was 
performed on frozen sections of liver tissue or cells in 
culture. Frozen sections or cells were fixed with 0.5% 
gluteraldehyde in PBS for 15 min, washed with PBS 
supplemented with 1 mM MgCl2 at pH5.5, and stained 
for 5–6 hours at 37°C without CO2 in PBS containing 1 
mM MgCl2 at pH5.5, 1mg/ml X-Gal, and 5 mM of both 
potassium ferricyanide and potassium ferrocyanide. 
Sections were counterstained with Eosin. 
 
Detection and modification of gene expression. For 
whole livers: lysates were generated using standard 
RIPA buffer supplemented with phosphatase inhibitors 
and protease inhibitors (both from Sigma). Detection of 
protein expression by immunoblotting in whole liver 
lysates was performed using anti-αSMA (Santa Cruz), 
anti-β-Tubulin (Sigma). For quantitative RT–PCR total 
RNA was isolated using NucleoSpin kit (Macherey 
Nagel, Düren, Germany) and 2 μg was reverse 
transcribed using the RevertAid H Minus First Strand 
cDNA synthesis Kit (Fermentas, Glen Burnie, MD, 
USA). The cDNA samples were amplified using Fast 
SYBR Green Master Mix in StepOnePlus Real-Time 
PCR System (both Applied Biosystems, Foster City, 
CA, USA). The relative expression of αSMA was 
normalized using the expression levels of GAPDH. 
  
For cell culture cells: lysates were generated using 
standard RIPA buffer supplemented with phosphatase 
inhibitors and protease inhibitors (both from Sigma). 
Detection of protein expression by immunoblotting in 
cell lysates were performed using anti-p-ERK (Sigma), 
anti-Total ERK (Sigma),β-Tubulin (Santa Cruz, CA, 
USA) and GAPDH (Millipore, MA, USA) . Total RNA 
from cells was isolated with NucleoSpin RNA II kit 
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(Macherey-Nagel, Germany). In all, 1 μg of RNA was 
reverse transcribed using MMLV reverse transcriptase 
(Promega, USA) and random hexamer primers 
(Amersham – GE Healthcare, USA). qRT-PCR was 
performed using SYBR Green Master Mix (Applied 
Biosystems, USA) in a StepOnePlus instrument 
(Applied Biosystems, USA). ON-TARGETplus 
SMARTpool small-interfering RNA targeting MICA 
and ULBP2, and the nontargeting (control) pool were 
transfected into growing IMR-90 cells with Dharmafect 
1 reagent (all from Dharmacon, Lafayette, CO, USA). 
Subsequently, cells were induced to senesce by 
Etoposide treatment.  
 
To inhibit ERK activity, senescent cells were incubated 
in the presence of 10μM of either the MEK inhibitors: 
of PD184352 (Sigma), AZD6244 (Axon Medchem, 
VA, USA) or Trametinib (GSK1120212) (Selleck 
Chemicals, Boston, USA) for 24, 48, 72 or 96 hr as 
indicated. To inhibit ATM activity growing cells were 
incubated in the presence of 10μM KU60019 (R&D 
Systems, USA) for 1 hr or 5mM caffeine (Sigma) and 
then treated with 100μM Etoposide for 24 hr. to inhibit 
ATM activity in senescent cells 10μM KU60019 (R&D 
Systems, USA) was add for 24, 48, 72 and 96 hr as 
indicated. All inhibitors were replenished daily. 
Subsequently total RNA was isolated and qRT-PCR 
was performed as described above. Primer list is 
available upon request. 
 
Image Stream Flow cytometry. Senescent or growing 
IMR-90 were harvested with TryplE (Gibco, Life 
Technologies, USA), collected with DMEM and 
centrifuged with the addition of EDTA 5mM. After a 
wash with cold PBS and transfer through mesh, cells 
were labeled with 10µg/ml of αMICA or αULBP2 in 
200µl of FACS buffer (5% FCS in PBS), on ice for one 
hour. Next cells were washed once with cold PBS and 
fluorescently labeled by a secondary α-mouse antibody 
(Jackson Immunoresearch, USA) at a concentration of 
1:200 in 200µl in FACS buffer for one hour on ice. At 
the end of incubation cells were washed twice with cold 
PBS and resuspended with DAPI 1:10,000 in FACS 
buffer to label dead cells. Finally, cells were imaged in 
an ImageStreamX system and analysis was done using 
the amnis IDEAS software package.  
 
Immunofluorescence (IF). IMR-90, WI38 and BJ cells 
were grown on 0.1% gelatin-coated coverslips. 
Subsequently, cells were blocked with human IgG and 
co-incubated with 10μg/ml of antibodies against either 
MICA, ULBP2 and isotype control for 1 hour at 4°C. 
then, the coverslips were washed with PBS, incubated 
with anti-mouse Alexa 549-conjugated secondary 
antibodies in PBS for 1 h at room temperature, washed 
again with PBS, fixed with 1% PFA for 15 minutes, and 
washed again in PBS containing DAPI and mounted in 
DAKO mounting medium. Fluorescence was detected 
using a Zeiss Axioscope II fluorescent microscope and 
image acquisition was conducted with simple PCI 
software. 
 
Statistical analysis. Data are expressed as mean + S.E. 
Statistical evaluation was carried out using Student’s t 
test (two-tailed) to test for differences between the 
control and experimental results. Values of p<0.05 were 
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